Published in:
Open Access
01-12-2015 | Research
Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK
Authors:
Liangqi Yao, Jipeng Wan, Hongyan Li, Jian Ding, Yanyun Wang, Xietong Wang, Mingjiang Li
Published in:
Reproductive Biology and Endocrinology
|
Issue 1/2015
Login to get access
Abstract
Background
Gestational diabetes mellitus (GDM) is a disease often manifests in mid to late pregnancy with symptoms including hyperglycemia, insulin resistance and fetal mal-development. The C57BL/KsJ-Lep
db/+
(db/+) mouse is a genetic GDM model that closely mimicked human GDM symptoms. Resveratrol (RV) is a naturally existing compound that has been reported to exhibit beneficial effects in treating type-2 diabetes.
Methods
In this study, we investigated the effect of RV on the pregnant db/+ GDM mouse model, and the underlying molecular mechanism.
Results
RV greatly improved glucose metabolism, insulin tolerance and reproductive outcome of the pregnant db/+ females. Moreover, we found that RV relieved GDM symptoms through enhancing AMPK activation, which in turn reduced production and activity of glucose-6-phosphatase in both pregnant db/+ females and their offspring.
Conclusions
Our findings further supported the potential therapeutic effect of RV on not only diabetes, but also alleviating GDM.